Quanterix (QTRX) Gains from Sales and Divestitures (2016 - 2024)
Quanterix (QTRX) reported Gains from Sales and Divestitures of $197000.0 for Q1 2024, down 56.51% quarter-over-quarter from $453000.0 in Q4 2023.
Quanterix (QTRX) Gains from Sales and Divestitures (2016 - 2024) Analysis & Trends
Quanterix has reported Gains from Sales and Divestitures for 9 years, with the latest figure at $197000.0 in Q1 2024.
- For the quarter ending Q1 2024, Gains from Sales and Divestitures changed N/A year-over-year to $197000.0; the trailing twelve-month figure through Mar 2024 stood at $197000.0 (changed N/A YoY), and the FY2023 full-year result was $453000.0, up 126.41% from the prior year.
- Gains from Sales and Divestitures for Q1 2024 stood at $197000.0, down from $453000.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $453000.0 in Q4 2023, with the low at $45474.0 in Q1 2020.
- Historically, Gains from Sales and Divestitures has averaged $186498.8 across 5 years, with a median of $176518.0 in 2020.
- Annual changes were most pronounced in 2022 — Gains from Sales and Divestitures dropped 25.12% — and 2023, when it surged 126.41%.
- Quanterix's Gains from Sales and Divestitures stood at $182036.0 in 2020, then surged by 46.78% to $267189.0 in 2021, then slipped by 25.12% to $200078.0 in 2022, then surged by 126.41% to $453000.0 in 2023, then plunged by 56.51% to $197000.0 in 2024.
- The last three Gains from Sales and Divestitures figures came in at $197000.0 (Q1 2024), $453000.0 (Q4 2023), and $171000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 197,000.00 |
| Mar 31, 2024 | 197,000.00 |
| Dec 31, 2023 | 453,000.00 |
| Dec 31, 2023 | 453,000.00 |
| Jun 30, 2023 | 171,000.00 |
| Jun 30, 2023 | 171,000.00 |
| Dec 31, 2022 | 200,078.00 |
| Dec 31, 2022 | 200,078.00 |
| Dec 31, 2021 | 267,189.00 |
| Dec 31, 2021 | 267,189.00 |
| Jun 30, 2021 | 133,732.00 |
| Jun 30, 2021 | 133,732.00 |
| Mar 31, 2021 | 85,346.00 |
| Mar 31, 2021 | 85,346.00 |
| Dec 31, 2020 | 182,036.00 |
| Dec 31, 2020 | 182,036.00 |
| Sep 30, 2020 | 130,133.00 |
| Sep 30, 2020 | 130,133.00 |
| Mar 31, 2020 | 45,474.00 |
| Mar 31, 2020 | 45,474.00 |